AR044363A1 - Derivados de benzoxazepinona, como inhibidores de gamma secretasa para el tratamiento de la enfermedad de alzheimer - Google Patents
Derivados de benzoxazepinona, como inhibidores de gamma secretasa para el tratamiento de la enfermedad de alzheimerInfo
- Publication number
- AR044363A1 AR044363A1 ARP040101685A ARP040101685A AR044363A1 AR 044363 A1 AR044363 A1 AR 044363A1 AR P040101685 A ARP040101685 A AR P040101685A AR P040101685 A ARP040101685 A AR P040101685A AR 044363 A1 AR044363 A1 AR 044363A1
- Authority
- AR
- Argentina
- Prior art keywords
- lower alkyl
- phenyl
- halogen
- substituted
- alzheimer
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- -1 tetrahydropyran-4-yl Chemical group 0.000 abstract 8
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical class 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- HZRJIAKKDMLYFS-UHFFFAOYSA-N 1,2-benzoxazepin-3-one Chemical class C1=CC(=O)NOC2=CC=CC=C21 HZRJIAKKDMLYFS-UHFFFAOYSA-N 0.000 abstract 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical group O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229910006074 SO2NH2 Inorganic materials 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La presente se refiere a derivados de benzoxazepinona de fórmula (1), en donde: R1 es hidrógeno, alcoxilo inferior, halógeno o -NR'R''; n es 1 ó 2; R', R'' son independientemente uno del otro hidrógeno o alquilo inferior; R2 es hidrógeno, alquilo inferior, -(CH2)m-cicloalquilo, -(CH2)m-fenilo o -(CH2)m-O-alquilo inferior; m es 0, 1 ó 2; R3 es alquilo inferior, -(CH2)m-C(O)O-alquilo inferior, cicloalquilo o -(CH2)m-fenilo, que está sin sustituir o sustituido por uno o dos sustituyentes, seleccionados del grupo constituido por halógeno o alquilo inferior; R4 es -(CH2)o-fenilo, que está sin sustituir o sustituido por uno o dos sustituyentes, seleccionados del grupo constituido por halógeno, trifluorometilo, -NR'R'', nitro o -SO2NH2, o es -cicloalquilo, sin sustituir o sustituido por fenilo, o es -(CR'R'')o-heterociclilo, seleccionado del grupo constituido por tetrahidropiran-4-ilo, piridin-3-ilo, indol-3-ilo, sustituido opcionalmente por halógeno o alcoxilo inferior, o tiofen-2- ilo, furan-2-ilo, -NH-piridin-2-ilo, sustituido opcionalmente por nitro, o benzoimidazol-2-ilo, 2-oxo-tetrahidrofurano, 1-bencil-piperidin-4-ilo, o benzo[1,3]dioxol-5-ilo o es tetrahidro-naftalen-1-ilo; CHR'-naftalen-2-ilo; fluoren-9-ilo; (CH2)o-S- alquilo inferior; (CH2)o-S-bencilo; (CH2)o-C(O)NH2; (CH2)oNR'R''; -H[C(O)NH2]-(CH2)o-fenilo; -(CH2)o-CF3; -(CH2)o-CR'R''-CH2-NR'R''; y o es 1 ó 2; y las sales de adición ácida farmacéuticamente aceptables de los mismos. Estos compuestos son buenos inhibidores de la g-secretasa para el tratamiento de la enfermedad de Alzheimer.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03011040 | 2003-05-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR044363A1 true AR044363A1 (es) | 2005-09-07 |
Family
ID=33442730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040101685A AR044363A1 (es) | 2003-05-19 | 2004-05-17 | Derivados de benzoxazepinona, como inhibidores de gamma secretasa para el tratamiento de la enfermedad de alzheimer |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7060698B2 (es) |
| EP (1) | EP1631296B1 (es) |
| JP (1) | JP4510021B2 (es) |
| KR (1) | KR100731368B1 (es) |
| CN (1) | CN1794997B (es) |
| AR (1) | AR044363A1 (es) |
| AT (1) | ATE360424T1 (es) |
| AU (1) | AU2004238037B2 (es) |
| BR (1) | BRPI0410647A (es) |
| CA (1) | CA2524640C (es) |
| CL (1) | CL2004001068A1 (es) |
| DE (1) | DE602004006118T2 (es) |
| ES (1) | ES2285458T3 (es) |
| MX (1) | MXPA05012368A (es) |
| MY (1) | MY143953A (es) |
| PL (1) | PL1631296T3 (es) |
| RU (1) | RU2332408C2 (es) |
| TW (1) | TWI290550B (es) |
| WO (1) | WO2004100958A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200502221A (en) | 2002-10-03 | 2005-01-16 | Astrazeneca Ab | Novel lactams and uses thereof |
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| US7060698B2 (en) * | 2003-05-19 | 2006-06-13 | Hoffmann-La Roche Inc. | Benzoxazepinone derivatives |
| WO2006050359A2 (en) | 2004-11-02 | 2006-05-11 | Northwestern University | Pyridazine compounds and methods |
| US7211573B2 (en) * | 2004-12-08 | 2007-05-01 | Hoffmann-La Roche Inc. | Malonamide derivatives |
| US20080311609A1 (en) * | 2004-12-14 | 2008-12-18 | Astrazeneca Ab | Novel Molecular Probes |
| RU2318818C1 (ru) * | 2006-04-12 | 2008-03-10 | Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" | Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты) |
| US8855099B2 (en) | 2007-03-19 | 2014-10-07 | Qualcomm Incorporated | Selective phase connection establishment |
| FR2913886B1 (fr) | 2007-03-22 | 2012-03-02 | Guerbet Sa | Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer |
| RU2345078C1 (ru) * | 2007-06-19 | 2009-01-27 | Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" | Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция, способ получения |
| JP5275315B2 (ja) * | 2010-10-01 | 2013-08-28 | 学校法人近畿大学 | 新規化合物及びβ−セクレターゼ阻害剤 |
| JP2014001142A (ja) * | 2010-10-05 | 2014-01-09 | Astellas Pharma Inc | シクロアルカン化合物 |
| US20140031547A1 (en) | 2010-12-14 | 2014-01-30 | Electrophoretics Limited | CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES |
| NO3175985T3 (es) * | 2011-07-01 | 2018-04-28 | ||
| WO2019173761A1 (en) | 2018-03-09 | 2019-09-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965553A (en) * | 1996-06-20 | 1999-10-12 | Pfizer Inc. | Squalene synthetase inhibitors |
| JP4274584B2 (ja) * | 1996-12-06 | 2009-06-10 | バーテックス ファーマシューティカルズ インコーポレイテッド | インターロイキン−１β変換酵素のインヒビター |
| JP2002080468A (ja) * | 2000-06-23 | 2002-03-19 | Takeda Chem Ind Ltd | ベンゾオキサゼピン化合物 |
| HUP0301301A2 (hu) | 2000-06-23 | 2003-08-28 | Takeda Chemical Industries Ltd. | Benzoxazepinon-származékok és szkvalén szintáz inhibitorként való alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények |
| GB0025173D0 (en) | 2000-10-13 | 2000-11-29 | Merck Sharp & Dohme | Therapeutic agents |
| US7060798B2 (en) * | 2002-05-13 | 2006-06-13 | State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Modified protein adhesives and lignocellulosic composites made from the adhesives |
| US7060698B2 (en) * | 2003-05-19 | 2006-06-13 | Hoffmann-La Roche Inc. | Benzoxazepinone derivatives |
-
2004
- 2004-05-03 US US10/838,054 patent/US7060698B2/en not_active Expired - Fee Related
- 2004-05-13 TW TW093113546A patent/TWI290550B/zh not_active IP Right Cessation
- 2004-05-14 JP JP2006529815A patent/JP4510021B2/ja not_active Expired - Fee Related
- 2004-05-14 DE DE602004006118T patent/DE602004006118T2/de not_active Expired - Lifetime
- 2004-05-14 MX MXPA05012368A patent/MXPA05012368A/es active IP Right Grant
- 2004-05-14 AT AT04732944T patent/ATE360424T1/de active
- 2004-05-14 ES ES04732944T patent/ES2285458T3/es not_active Expired - Lifetime
- 2004-05-14 WO PCT/EP2004/005177 patent/WO2004100958A1/en not_active Ceased
- 2004-05-14 RU RU2005139529/04A patent/RU2332408C2/ru not_active IP Right Cessation
- 2004-05-14 BR BRPI0410647-4A patent/BRPI0410647A/pt not_active IP Right Cessation
- 2004-05-14 PL PL04732944T patent/PL1631296T3/pl unknown
- 2004-05-14 CA CA2524640A patent/CA2524640C/en not_active Expired - Fee Related
- 2004-05-14 KR KR1020057021910A patent/KR100731368B1/ko not_active Expired - Fee Related
- 2004-05-14 CN CN2004800140158A patent/CN1794997B/zh not_active Expired - Fee Related
- 2004-05-14 EP EP04732944A patent/EP1631296B1/en not_active Expired - Lifetime
- 2004-05-14 AU AU2004238037A patent/AU2004238037B2/en not_active Ceased
- 2004-05-17 AR ARP040101685A patent/AR044363A1/es unknown
- 2004-05-17 CL CL200401068A patent/CL2004001068A1/es unknown
- 2004-05-18 MY MYPI20041936A patent/MY143953A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200510355A (en) | 2005-03-16 |
| CL2004001068A1 (es) | 2005-04-15 |
| JP2007501261A (ja) | 2007-01-25 |
| MXPA05012368A (es) | 2006-02-02 |
| CN1794997A (zh) | 2006-06-28 |
| EP1631296A1 (en) | 2006-03-08 |
| CA2524640C (en) | 2011-10-11 |
| PL1631296T3 (pl) | 2007-08-31 |
| DE602004006118T2 (de) | 2008-01-03 |
| AU2004238037B2 (en) | 2009-11-26 |
| CN1794997B (zh) | 2010-05-12 |
| US20040235819A1 (en) | 2004-11-25 |
| US7060698B2 (en) | 2006-06-13 |
| MY143953A (en) | 2011-07-29 |
| JP4510021B2 (ja) | 2010-07-21 |
| TWI290550B (en) | 2007-12-01 |
| EP1631296B1 (en) | 2007-04-25 |
| CA2524640A1 (en) | 2004-11-25 |
| DE602004006118D1 (de) | 2007-06-06 |
| ATE360424T1 (de) | 2007-05-15 |
| KR100731368B1 (ko) | 2007-06-21 |
| BRPI0410647A (pt) | 2006-07-04 |
| RU2332408C2 (ru) | 2008-08-27 |
| ES2285458T3 (es) | 2007-11-16 |
| KR20060003107A (ko) | 2006-01-09 |
| RU2005139529A (ru) | 2006-08-10 |
| AU2004238037A1 (en) | 2004-11-25 |
| WO2004100958A1 (en) | 2004-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR079327A1 (es) | Derivados de 2-amino-5,5-difluor -5,6-dihidro-4h-(1,3) oxazin-4-il) fenil)-amida | |
| AR052903A1 (es) | Compuestos de bis arilo y heteroarilo sustituidos como antagonistas selectivos de 5ht2a, composiciones farmaceuticas que los contienen y su empleo en el tratamiento de trastornos del sueno. | |
| AR078163A1 (es) | Utilizacion de aminodihidrotiazinas para el tratamiento o prevencion de la diabetes | |
| CY1118723T1 (el) | Ενωσεις βενζοθειαζολιου και αζαβενζοθειαζολιου χρησιμες ως αναστολεiς κινασης | |
| EA200970461A1 (ru) | ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 3-ИЗОБУТИЛ-9,10-ДИМЕТОКСИ-1,3,4,6,7,11b-ГЕКСАГИДРО-2Н-ПИРИДО[2,1-a]ИЗОХИНОЛИН-2-ОЛА И СВЯЗАННЫЕ С НИМИ СПОСОБЫ | |
| PE20090042A1 (es) | Analogos de ciclopamina | |
| AR058287A1 (es) | Derivados de isoquinolina y composicion farmaceutica | |
| AR032436A1 (es) | Oxazolidinonas substituidas, procedimiento para su preparacion, medicamentos, el uso de las mismas para la fabricacion de medicamentos, y el metodo para impedir la coagulacion sanguinea in vitro | |
| PE20091621A1 (es) | Derivados de amina como moduladores de la actividad de tlr y composiciones que los contienen | |
| AR077935A1 (es) | Derivados de 3-amino-5 fenil-5,6-dihidro-2h-(1,4)oxazina | |
| UY31126A1 (es) | Derivados de quinoxalina como inhibidores de la actividad de cinasa de tirosina de las cinasas janus | |
| PE20070218A1 (es) | COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA | |
| AR054799A1 (es) | Derivados de oxindol | |
| ECSP088129A (es) | Derivado novedoso de heterocicliden acetamida | |
| NO20075641L (no) | Kroman og kromenderivater og ders anvendelse | |
| CO5690643A2 (es) | Derivados de triaza-espiropiperidina para usarlos como inhibidores de glyt-1 en el tratamiento de desordenes neurologicos y neuropsiquiatricos | |
| AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| PE20090189A1 (es) | Derivados de aza-piridopirimidinona como agonistas de hm74a | |
| AR035235A1 (es) | Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento | |
| NO20063469L (no) | Polyeheterosykliske forbindelser og deres anvendelse som metabotrofe glutamat reseptorantagonister | |
| AR071925A1 (es) | Malonamidas como antagonistas de orexina | |
| AR074604A1 (es) | Derivados de 5-amino-2-(1-hidroxi-etil)-tetrahidropirano. | |
| AR065587A1 (es) | Aminoamidas como antagonistas de orexina | |
| AR074817A1 (es) | Dihidropiridona-amidas como moduladores de p2x7 | |
| AR039651A1 (es) | Derivados de isoquinolina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |